3.3(top 25%)
Impact Factor
3.6(top 25%)
extended IF
116(top 3%)
H-Index
3.1K
authors
7.8K
papers
102.8K
citations
6.3K
citing journals
53K
citing authors

Most Cited Articles of Value in Health

TitleYearCitations
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation20052.3K
Medication compliance and persistence: terminology and definitions20081.4K
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force20131.3K
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force2011947
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets2012946
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force2013811
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies2003770
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 12011673
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding2011572
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument2011552
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force2014551
Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?2004537
Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force2016483
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report2005481
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 22011478
Patient-reported outcomes to support medical product labeling claims: FDA perspective2007469
QALYs: the basics2009441
A checklist for medication compliance and persistence studies using retrospective databases2007440
Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review2008426
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report2007408
Dutch Tariff for the Five-Level Version of EQ-5D2016400
Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues2004399
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research2016382
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement2013381
Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials2008374